Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950170-25-048016
Filing Date
2025-04-01
Accepted
2025-04-01 06:51:31
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1/A apvo-2025-s1a4_-_march_o.htm S-1/A 999725
2 EX-5.1 apvo-ex5_1.htm EX-5.1 34972
3 EX-23.1 apvo-ex23_1.htm EX-23.1 3762
4 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 110352
5 GRAPHIC img57496738_0.jpg GRAPHIC 12962
6 GRAPHIC img77271898_0.jpg GRAPHIC 6733
7 GRAPHIC img77271898_1.jpg GRAPHIC 199177
8 GRAPHIC img77271898_2.jpg GRAPHIC 250435
9 GRAPHIC img77271898_3.jpg GRAPHIC 14823
  Complete submission text file 0000950170-25-048016.txt   1817057
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-285476 | Film No.: 25796523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)